Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16
Not Applicable
Completed
- Conditions
- Opioid-Related DisordersSubstance-Related Disorders
- Interventions
- Drug: 30% Nitrous oxideOther: 0.35 g/Kg ethanolOther: 0 g/Kg ethanolOther: 0.7 g/Kg ethanol
- Registration Number
- NCT00000264
- Lead Sponsor
- University of Chicago
- Brief Summary
The purpose of this study is to examine the subjective, psychomotor, and reinforcing effects of combined alcohol and nitrous oxide intake in healthy volunteers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description 0.35 g/Kg ethanol +/- 30% nitrous oxide 0.35 g/Kg ethanol - 0.35 g/Kg ethanol +/- 30% nitrous oxide 30% Nitrous oxide - 0 g/Kg ethanol +/- 30% nitrous oxide 30% Nitrous oxide - 0 g/Kg ethanol +/- 30% nitrous oxide 0 g/Kg ethanol - 0.7 g/Kg ethanol +/- 30% nitrous oxide 0.7 g/Kg ethanol - 0.7 g/Kg ethanol +/- 30% nitrous oxide 30% Nitrous oxide -
- Primary Outcome Measures
Name Time Method Mood Baseline and post inhalation Psychomotor performance Baseline and post inhalation Cognitive performance Baseline and post inhalation Choice of nitrous oxide vs placebo after each ethanol session
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms mediate the synergistic psychomotor effects of ethanol and nitrous oxide in substance use disorder models?
How does combined ethanol-nitrous oxide exposure compare to standard opioid substitution therapies in reinforcing effect profiles?
Which biomarkers correlate with differential response to ethanol-nitrous oxide combinations in individuals with substance-related disorders?
What adverse event management protocols are recommended for concurrent ethanol and nitrous oxide administration in clinical trials?
Are there alternative NMDA receptor antagonists or GABA modulators with similar reinforcing effects when combined with ethanol in addiction research?
Trial Locations
- Locations (1)
University of Chicago, Anesthesia & Critical Care
🇺🇸Chicago, Illinois, United States